{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-170","focus_area":"Twin Delivery IUFD and Hydrops Framework","tags":["usmle-step2","obstetrics","twins","iufd","hydrops"],"text":"# Twin Delivery Rules + IUFD + Hydrops Basics\n## Twin delivery\n- Twin A presentation이 분만 전략 결정.\n- Twins에서는 ECV 금기(placental abruption/cord complication 위험).\n- Vasa previa는 막 파열 시 fetal exsanguination 위험으로 즉시 C-section.\n\n## IUFD\n- 확진: real-time ultrasound로 cardiac activity 부재 확인.\n- 기본 관리: 유도분만 통한 vaginal delivery 선호(미래 임신의 uterine scar risk 최소화).\n- 예외적 수술 적응증: classical scar, placenta previa, 산모 응급상황.\n- 장기 지연 위험: retained fetus로 DIC 가능.\n\n## Hydrops fetalis\n- 2개 이상 compartment fluid accumulation(skin edema/ascites/effusion).\n- severe anemia -> high-output cardiac failure -> generalized edema."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-190","focus_area":"Hydrops Etiology and HTN Disorders Intro","tags":["usmle-step2","obstetrics","hydrops","rh-incompatibility","preeclampsia"],"text":"# Hydrops Causes and Hypertensive Disorders Entry\n## Hydrops causes\n- Immune: Rh incompatibility(hemolysis).\n- Non-immune(현대에 더 흔함): parvovirus B19(erythroid suppression), alpha-thalassemia major(Hb Barts), 일부 염색체/구조 이상.\n\n## Rapid recap points\n1. IUGR + reverse end-diastolic flow -> 즉시 분만 고려.\n2. Twin A breech in twins -> 수술분만 우선.\n3. IUFD 진단은 실시간 초음파.\n4. IUFD는 산모 미래 위험 최소화 관점으로 유도분만 우선.\n5. Hydrops 핵심병태는 severe fetal anemia.\n\n## Hypertensive disorders core frame\n- 20주 이전 고혈압은 chronic HTN 가능성.\n- 20주 이후 placenta-related disease spectrum(gestational HTN, preeclampsia, eclampsia)로 접근."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-210","focus_area":"Hypertensive Disorder Classification and Severe Features","tags":["usmle-step2","obstetrics","hypertension","preeclampsia","eclampsia"],"text":"# Hypertensive Disorders in Pregnancy: Classification and Severe Features\n| Disorder | Timing | Key finding |\n| --- | --- | --- |\n| Chronic HTN | <20주 또는 임신 전부터 | baseline HTN |\n| Gestational HTN | >=20주 | HTN only, proteinuria/end-organ 없음 |\n| Preeclampsia | >=20주 | HTN + proteinuria 또는 end-organ damage |\n| Superimposed preeclampsia | chronic HTN 위에 발생 | BP 악화/새 단백뇨/장기손상 |\n| Eclampsia | preeclampsia with seizure | 경련 동반 |\n\n## Severe features\n- BP >=160/110.\n- platelet <100k.\n- LFT 상승 또는 심한 RUQ/epigastric pain.\n- Cr >1.1 또는 baseline의 2배.\n- pulmonary edema.\n- 지속 두통/시야증상.\n\n## Eclampsia acute priorities\n1. magnesium sulfate.\n2. 산모 안정화(airway/positioning).\n3. 안정 후 분만."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-230","focus_area":"Preeclampsia Pharmacology HELLP and AFLP","tags":["usmle-step2","obstetrics","magnesium","hellp","aflp"],"text":"# Management of Severe Preeclampsia and Hepatic Mimics\n## Antihypertensives in pregnancy\n- labetalol, hydralazine, nifedipine 사용.\n- ACEi/ARB 금기.\n\n## Magnesium sulfate\n- 목적: seizure prophylaxis(혈압약 아님).\n- 독성 진행: DTR 소실 -> 호흡저하 -> 심정지.\n- 해독제: calcium gluconate.\n- 주의: myasthenia gravis, renal failure.\n\n## Fluid principle\n- intravascularly dry but extravascular edema 상태 가능.\n- diuretic은 폐부종 등 선택적 상황에서만 사용.\n\n## HELLP\n- hemolysis + elevated liver enzymes + low platelets.\n- definitive management는 분만.\n\n## AFLP vs HELLP\n- AFLP는 간 합성기능 저하(저혈당, INR/PT 연장, 암모니아 상승) 단서가 더 뚜렷."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-245","focus_area":"Rapid Recap Severe HTN Disorders","tags":["usmle-step2","obstetrics","recap","preeclampsia","hellp"],"text":"# Rapid Recap: Hypertensive Emergencies\n1. 20주 이전 HTN은 chronic HTN 우선.\n2. 160/110 + 두통/단백뇨는 severe preeclampsia로 즉시 안정화 후 분만 계획.\n3. Mg 사용 중 DTR 소실/호흡저하는 magnesium toxicity, calcium gluconate 투여.\n4. RUQ pain + thrombocytopenia는 HELLP 의심.\n5. 저혈당 + coagulopathy는 AFLP 쪽 단서."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-255","focus_area":"AFLP Clinical Scenario","tags":["usmle-step2","obstetrics","aflp","liver-failure"],"text":"# AFLP Scenario Anchor\n- 3분기 산모의 nausea/vomiting + jaundice + hypoglycemia + INR 상승은 AFLP를 강하게 시사.\n- management는 산모 안정화(포도당/응고관리)와 신속한 분만."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-1","focus_area":"Gestational Diabetes Screening Diagnosis","tags":["usmle-step2","obstetrics","gdm","screening","gtt"],"text":"# Gestational Diabetes: Screening and Diagnostic Algorithm\n## Pathophysiology\n- placental hormone(HPL) 증가로 maternal insulin resistance가 후기 임신에서 증가.\n\n## Who and when to screen\n- 기본: 24-28주.\n- 고위험(비만 + 위험인자)에서는 첫 방문 즉시 검사 후, 초기 음성이어도 24-28주 재검.\n\n## Two-step test\n| Step | Test | Rule |\n| --- | --- | --- |\n| 1 | 50g GCT(non-fasting) | 1시간 값 >=140이면 step 2 |\n| 2 | 100g OGTT(fasting) | 공복/1h/2h/3h 중 2개 이상 이상이면 GDM |\n\n## Carpenter-Coustan cutoffs\n- Fasting 95, 1h 180, 2h 155, 3h 140."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-21","focus_area":"GDM Management and Complications","tags":["usmle-step2","obstetrics","gdm","insulin","neonatal-complications"],"text":"# GDM Management and Maternal-Fetal Complications\n## Treatment hierarchy\n- 1차: 식이/운동 + glucose monitoring.\n- 목표: fasting <=95, 1h postprandial <=140, 2h <=120.\n- 조절 실패 시 insulin이 보드 기준 1순위(placenta 통과 안 함).\n\n## Complications by timing\n- 임신 초기 고혈당(대개 pre-existing DM): congenital anomaly risk(예: caudal regression).\n- GDM 후기 영향: fetal hyperinsulinemia -> macrosomia, shoulder dystocia.\n\n## Neonatal\n- hypoglycemia, polycythemia, jaundice, hypocalcemia/hypomagnesemia, RDS risk 증가.\n- 일부는 transient hypertrophic cardiomyopathy 동반 가능.\n\n## Postpartum\n- 6-12주 75g 2h OGTT로 재평가, 장기적 T2DM 추적 필요."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-41","focus_area":"Rapid Recap GDM and Labor Transition","tags":["usmle-step2","obstetrics","recap","gdm","labor"],"text":"# Rapid Recap: GDM Essentials\n| Scenario | Interpretation | Action |\n| --- | --- | --- |\n| BMI 높고 GDM 과거력 | high-risk pregnancy | 첫 방문 즉시 GDM screen |\n| 50g GCT >=140 | screen positive | 100g OGTT 진행 |\n| OGTT 2개 이상 이상 | GDM 확진 | lifestyle -> 필요 시 insulin |\n| 임신 중 조절불량 고혈당 | macrosomia/shoulder dystocia 위험 | 분만계획 시 난산 대비 |\n| 산후 평가 | T2DM 고위험군 | 6-12주 75g OGTT |\n\n## Next unit\n- labor timing(too early vs too late)과 출혈 응급 분기."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-51","focus_area":"Preterm Labor Zones and Deceleration Logic","tags":["usmle-step2","obstetrics","preterm-labor","tocolysis","deceleration"],"text":"# Preterm Labor Zone Strategy and FHR Pattern Logic\n## Preterm labor diagnosis\n- 규칙적 수축 + cervical change가 함께 있어야 진단.\n\n## Gestational age-based strategy\n| Zone | GA | Management highlights |\n| --- | --- | --- |\n| Zone 1 | <32주 | magnesium(neuroprotection) + indomethacin + steroid + GBS coverage |\n| Zone 2 | 32-34주 | nifedipine 중심, indomethacin 장기 사용 회피(ductus closure risk) |\n| Zone 3 | 34-37주 | tocolysis 이득 낮아 분만 진행 허용 |\n\n## Deceleration\n- Early: head compression(대개 생리적).\n- Variable: cord compression(V/W shape, low fluid/ROM 관련)."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-71","focus_area":"Breech ECV Shoulder Dystocia Postterm","tags":["usmle-step2","obstetrics","breech","ecv","shoulder-dystocia","postterm"],"text":"# Breech, ECV, Shoulder Dystocia, and Postterm Management\n## Breech with non-viable fetus\n- non-viable 상태에서는 산모 위험 최소화를 위해 vaginal delivery 선택 가능.\n\n## ECV\n- 37주 전후 selected case에서 고려.\n- rupture of membranes, fetal distress 등은 금기.\n\n## Internal podalic version\n- twin A 분만 후 twin B 조작에 제한적으로 사용.\n\n## Shoulder dystocia\n- turtle sign은 즉시 산과적 응급처치 필요.\n- 위험인자: macrosomia(GDM/postterm).\n\n## Postterm\n- 41주 이후 태반 기능 저하와 oligohydramnios/cord compression 위험 증가.\n- 41-42주 사이 유도분만 고려, 무기한 대기 금지."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-88","focus_area":"Rapid Recap Preterm to Third Trimester Bleed","tags":["usmle-step2","obstetrics","recap","preterm-labor","postterm","third-trimester-bleeding"],"text":"# Rapid Recap: Labor Timing and Bleeding Entry\n| Scenario | Key point | Action |\n| --- | --- | --- |\n| 29주 preterm labor | zone 1 | neuroprotection + tocolysis + steroid |\n| 33주 labor | zone 2 | nifedipine 중심 전환 |\n| deep variable decel | cord compression | maternal reposition, fluid/context 교정 |\n| postterm physiology | placental aging | oligohydramnios/난산/사산 위험 평가 |\n\n## Next unit\n- third-trimester bleeding은 pain vs painless, uterine tone, fetal status로 즉시 분기."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-98","focus_area":"Third Trimester Bleeding Differential and Management","tags":["usmle-step2","obstetrics","placenta-previa","vasa-previa","abruption","uterine-rupture"],"text":"# Third Trimester Bleeding: Previa vs Vasa vs Rupture vs Abruption\n## First split: painful vs painless + uterine tone\n- soft/painless uterus는 previa/vasa 쪽.\n- board-like painful uterus는 abruption/rupture 쪽 응급.\n\n## Placenta previa\n- painless bleeding + soft uterus.\n- 디지털 질검사 금지.\n- 진단은 ultrasound, 분만은 계획 C-section(보통 36-37주 전후).\n\n## Vasa previa\n- ROM 직후 출혈 + fetal bradycardia/sinusoidal이면 fetal blood loss 의심.\n- 즉시 C-section.\n\n## Uterine rupture\n- TOLAC 중 sudden tearing pain, contraction 소실, fetal station loss.\n- 즉시 laparotomy/응급수술.\n\n## Placental abruption\n- painful bleeding, hypertonic uterus, concealed hemorrhage 가능.\n- 진단은 임상 중심(US 음성이어도 배제 불가).\n- fibrinogen 저하/DIC 위험 모니터링.\n- 안정 시 vaginal delivery 가능, 불안정/태아곤란 시 operative delivery."}
